PlainRecalls
FDA Drug Critical Class I Terminated

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.

Reported: May 7, 2014 Initiated: December 23, 2013 #D-1278-2014

Product Description

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.

Reason for Recall

Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Details

Recalling Firm
Hospira Inc.
Units Affected
68,350 vials
Distribution
Nationwide
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.. Recalled by Hospira Inc.. Units affected: 68,350 vials.
Why was this product recalled?
Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 7, 2014. Severity: Critical. Recall number: D-1278-2014.